| Urania Therapeutics–Advent France Biotechnology: investment, 201911 seed financing round totalling €3.53m incl lead investor AFB |
2019-11-06 |
| Urania Therapeutics–Andrew Lloyd Associates: public relations, 201911 service existent by ALA |
2019-11-06 |
| Urania Therapeutics–Capital Grand Est: investment, 201911 seed financing round totalling €3.53m incl co-investor Cap Innov’Est |
2019-11-06 |
| Urania Therapeutics–Novalix: drug development services, 201911– supply of drug development services to Urania by Novalix |
2019-11-06 |
| Urania Therapeutics–SEVERAL: investment, 201911 seed financing round €3.53m led by Advent France Biotechnology + incl Cap Innov’Est |
2019-11-06 |
| Poxel–IPF Partners: credit, 201911–201412 bond loan up to €30m in three tranches 11/19 + 3/20 + 12/21 |
2019-11-05 |
| Pieris–SEVERAL: investment, 201911 private placement $32m w 9.015m units (shares + warrants) at $3.55/unit led by BVF Partners |
2019-11-04 |
| genOway–Institut Pasteur: transgenic anmials, 201910– license extension from IP + Cellectis to genOway to take legal actions against infringement |
2019-10-30 |
| Innate Pharma–SEVERAL: investment, 201910 pirvate placement €22.13m with 4.45m ordinary shares at €4.97/share |
2019-10-21 |
| Sofinnova–SEVERAL: investment, 201910 closing €333m of Sofinnova Capital IX fund |
2019-10-17 |
| Aeovian Pharmaceuticals–Apollo Ventures: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Apollo Health Ventures |
2019-10-03 |
| Aeovian Pharmaceuticals–Evotec: investment, 201910 financing round Series A totalling $37m incl founding + co-investor Evotec |
2019-10-03 |
| Aeovian Pharmaceuticals–SEVERAL: investment, 201910 financing round Series A $37m led by VenBio + Sofinnova Investments |
2019-10-03 |
| Aeovian Pharmaceuticals–Sofinnova: investment, 201910 financing round Series A totalling $37m incl new + co-lead investor Sofinnova Investments |
2019-10-03 |
| Aeovian Pharmaceuticals–VenBio: investment, 201910 financing round Series A totalling $37m incl new + co-lead investor VenBio Partners |
2019-10-03 |
| Cellectis–Lonza: cell therapy contract manufacturing, 201910– supply UCART cell therapy candidates by Lonza in Geleen (NL) |
2019-10-01 |
| Tacalyx–SEVERAL: investment, 201909 seed financing round €7m co-led by BIVF + Kurma Partners |
2019-09-25 |
| Innate Pharma–SEVERAL: investment, 201909–201910 US IPO $54.5m with 9.922m ADSs at $5.5/ADS + listing of ADSs at Nasdaq Global Select Market |
2019-09-20 |
| Themis Bioscience–SEVERAL: investment, 201909 financing round Series D €40m co-led by Farallon Capital + Hadean Ventures |
2019-09-18 |
| Inotrem–Andera Partners: investment, 201909 financing round Series B totalling €39m incl exisiting + co-investor Andera Partners |
2019-09-12 |
| Inotrem–BioMedPartners: investment, 201909 financing round Series B totalling €39m incl exisiting + co-investor BioMedInvest |
2019-09-12 |
| Inotrem–Invus Group: investment, 201909 financing round Series B totalling €39m incl co-investor Invus |
2019-09-12 |
| Inotrem–Morningside: investment, 201909 financing round Series B totalling €39m incl lead investor Morningside Ventures |
2019-09-12 |
| Inotrem–SEVERAL: investment, 201909 financing round Series B €39m led by Morningside Ventures |
2019-09-12 |
| Inotrem–Sofinnova: investment, 201909 financing round Series B totalling €39m incl exisiting + co-investor Sofinnova Partners |
2019-09-12 |
| Ermium Therapeutics–SEVERAL: investment, 201909 financing round Series A €6.3m from Domain Therapeutics + Kurma Partners + Idinvest + SATT Erganeo |
2019-09-11 |
| Keranova–SEVERAL: investment, 201909 2nd financing round €24m incl Mérieux Equity Partners + Supernova Invest + Arbevel + TI-invest |
2019-09-10 |
| Pharvaris–SEVERAL: investment, 201909 financing round Series B $66m led by Foresite Capital |
2019-09-10 |
| iStar Medical–SEVERAL: investment, 201905 financing round Series C €40m led by LSP + Gimv |
2019-09-05 |
| TreeFrog Therapeutics–EU (govt): grant, 201909– Horizon 2022 SME Instrument Program Phase 2 Grant €2.4m |
2019-09-05 |
| TreeFrog Therapeutics–France (govt): grant, 201909–2020 grant €450k from Bpifrance i-Nov Innovation Challenge Phase 2 |
2019-09-05 |
| HiFiBio–Delian Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Delian Capital |
2019-08-28 |
| HiFiBio–Gilead: investment, 201908 financing round Series C totalling $67m incl new + co-investor Kite |
2019-08-28 |
| HiFiBio–Hanne Capital: investment, 201908 financing round Series C totalling $67m incl new + co-investor Hanne Capital |
2019-08-28 |
| HiFiBio–IDG Capital: investment, 201908 financing round Series C totalling $67m incl new + lead investor IDG Capital |
2019-08-28 |
| HiFiBio–Legend Star Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Legend Star Capital |
2019-08-28 |
| HiFiBio–Lyfe Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Lyfe Capital |
2019-08-28 |
| HiFiBio–Sequoia Capital: investment, 201908 financing round Series C totalling $67m incl existing + co-investor Sequoia Capital China |
2019-08-28 |
| HiFiBio–SEVERAL: investment, 201908 financing round Series C $67m led by new investor IDG Capital |
2019-08-28 |
| HiFiBio–VI Ventures: investment, 201908 financing round Series C totalling $67m incl existing + co-investor VI Ventures |
2019-08-28 |
| Blue Heron–Eurofins: investment, 201908 acquisition of Blue Heron Biotech by Eurofins Genomics LLC |
2019-08-06 |
| Alizé Pharma–SEVERAL: investment, 201907 financing round Series A €67m of Alizé Pharma 3 led by LSP |
2019-07-31 |
| Twist Bioscience–Imagene: nucleic acid storage technology, 201907– supply service DNA encapsulation using DNAshell technology |
2019-07-25 |
| Infarco–Keensight Capital: investment, 201907 acquisition of Infarco’s majority stake in 3P Biopharmaceuticals by Keensight |
2019-07-23 |
| Medicxi Ventures–JnJ: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC |
2019-07-19 |
| Medicxi Ventures–Novartis: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC |
2019-07-19 |
| Medicxi Ventures–SEVERAL: investment, 201907 closing €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC |
2019-07-19 |
| BiomX–SEVERAL: investment, 201907–201910 listing at NYSE via SPAC merger with $60m in trust account |
2019-07-17 |
| Pyxis Oncology–SEVERAL: investment, 201907 financing round Series A $22m led by Leaps by Bayer |
2019-07-17 |
| AM-Pharma–SEVERAL: investment, 201907 financing round €116m co-led by LSP + Andera Partners |
2019-07-16 |
| BPCE–Illumina: business services, 201907– collab Illumina Accelerator UK + Seventure Partners to provide funding + lab services + coaching to startups |
2019-07-16 |
| Sofinnova–Illumina: business services, 201907– collab Illumina Accelerator UK to provide funding + lab services + coaching to startups |
2019-07-16 |
| Genmab–Blink Biomedical: therapeutic antibodies, 201907– license to use CD47 Abs in DuoBodies $2.25m upfront + up to $200m per product plus royalties |
2019-07-12 |
| Microphyt–CEA Industrie: investment, 201907 financing round totalling €28.5m incl existing + co-investor Supernova Invest |
2019-07-11 |
| Microphyt–Demeter: investment, 201907 financing round totalling €28.5m incl existing + co-investor Demeter Partners |
2019-07-11 |
| Microphyt–France (govt): investment, 201907 financing round totalling €28.5m incl new + co-lead investor Bpifrance SPI Fund |
2019-07-11 |
| Microphyt–Irdi Soridec: investment, 201907 financing round totalling €28.5m incl existing + co-investor Irdi Soridec |
2019-07-11 |
| Microphyt–iXO Private Equity: investment, 201907 financing round totalling €28.5m incl new + co-investor iXO Private Equity |
2019-07-11 |
| Microphyt–Safilaro: investment, 201907 financing round totalling €28.5m incl new + co-investor Sofilaro |
2019-07-11 |
| Microphyt–SEVERAL: investment, 201907 financing round €28.5m co-led by Sofinnova Partners + Bpifrance SPI Fund |
2019-07-11 |
| Microphyt–Sofinnova: investment, 201907 financing round totalling €28.5m incl new + co-lead investor Sofinnova Partners |
2019-07-11 |
| Nosopharm–Evotec: antibiotics, 201907– collab €na pre-clinical developm of NOSO-502 + 2nd generation odilorhabdin |
2019-07-03 |
| Oncovita–Andrew Lloyd Associates: public relations, 201907 service existent by ALA |
2019-07-02 |
| Oncovita–Institut Pasteur: cancer immunotherapy, 201907– license excl ww €na for use of oncolytic measles virus platform for product developm + sale |
2019-07-02 |
| Oncovita–Institut Pasteur: investment, 201907 existent Institut Pasteur is shareholder of Oncovita |
2019-07-02 |
| Sanifit–Andera Partners: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Andera Partners |
2019-06-26 |
| Sanifit–la Caixa: investment, 201906 financing round Series D totalling €55.2m incl existing + lead investor Caixa Capital Risc |
2019-06-26 |
| Sanifit–SEVERAL: investment, 201906 financing round Series D €55.2m led by Caixa Capital Risc |
2019-06-26 |
| Sanifit–SEVERAL: investment, 201906c capitalisation of €17m of convertible bonds |
2019-06-26 |
| Vesalius Biocapital–SEVERAL: investment, 201906 final closing of €120m Vesalius Biocapital III fund |
2019-06-25 |
| SQZ Biotechnologies–Erytech: drug delivery technology, 201906– license to red blood cell encapsulation from Erytech to develop immunomodulators |
2019-06-24 |
| Terns Pharmaceuticals–Genfit: elafibranor, 201906– license excl $35m upfront + $193m milestones + royalties for Greater China |
2019-06-24 |
| Sanofi–Alphabet: healthcare informatics, 201906– collab new virtual innovation lab using Google Cloud for future medicines + healthcare services |
2019-06-18 |
| Ipsen–Debiopharm: triptorelin, 201906– strategic collab extension 15y developm + prod + distrib Decapeptyl in Europe + certain Asia + Africa |
2019-06-12 |
| Medidata Solutions–Dassault Systèmes: investment, 201906– acquisition $5.8b cash tender offer at $92.25/share ANNOUNCED |
2019-06-12 |
| Servier–Yposkesi: lentiviral vectors, 201906– collab developm + GMP manufacture of lentiviral vectors for CAR-T cell technology development |
2019-06-05 |
| Yukin Therapeutics–Advent France Biotechnology: investment, 201906 financing round totalling €3.3m incl founding + co-lead investor Advent France Bio |
2019-06-04 |
| Yukin Therapeutics–Medicxi Ventures: investment, 201906 financing round totalling €3.3m incl new + co-lead investor Medicxi |
2019-06-04 |
| Yukin Therapeutics–NewCap: public relations, 201906 service existent by NewCap |
2019-06-04 |
| Yukin Therapeutics–SEVERAL: investment, 201906 financing round €3.3m co-led by Advent France Biotechnology + Medicxi |
2019-06-04 |
| Domain Therapeutics–BPCE: investment, 201905 investment €3.5m from existing investor Seventure Partners |
2019-05-28 |
| Sensorion–Institut Pasteur: gene therapy, 201905– collab framework agreem incl license options for gene therapies for ear diseases |
2019-05-27 |
| DNA Script–France (govt): investment, 201905 financing round Series B totalling $38.5m incl new investor Bpifrance Large Venture fund |
2019-05-16 |
| DNA Script–Idinvest Partners: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Idinvest Partners |
2019-05-16 |
| DNA Script–Illumina: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Illumina Ventures |
2019-05-16 |
| DNA Script–Kurma: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Kurma Partners |
2019-05-16 |
| DNA Script–Life Sciences Partners: investment, 201905 financing round Series B totalling $38.5m incl new + lead investor LSP |
2019-05-16 |
| DNA Script–Merck (DE): investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor M Ventures |
2019-05-16 |
| DNA Script–SEVERAL: investment, 201905 financing round Series B $38.5m led by LSP |
2019-05-16 |
| DNA Script–Sofinnova: investment, 201905 financing round Series B totalling $38.5m incl existing + co-investor Sofinnova Partners |
2019-05-16 |
| TreeFrog Therapeutics–Andrew Lloyd Associates: public relations, 201905 service existent by ALA |
2019-05-13 |
| TreeFrog Therapeutics–SEVERAL: investment, 201905 financing round Series A €6.5m led by XAnge + incl Galia Geston et al |
2019-05-13 |
| Therachon–Cowen: investment, 201905 existing investor Cowen |
2019-05-08 |
| Therachon–France (govt): investment, 201905 existing investors Bpifrance + Inserm Transfert Initiative |
2019-05-08 |
| Therachon–Novo Group: investment, 201905 existing investor Novo Holdings |
2019-05-08 |
| Therachon–OrbiMed: investment, 201905 existing investor OrbiMed |
2019-05-08 |
| Therachon–Pfizer: investment, 201905 existing investor Pfizer Ventures |
2019-05-08 |
| Therachon–Pfizer: investment, 201905– acquisition 100% $340m upfront + $470m milestones excl apraglutide development program |
2019-05-08 |
| Therachon–Tekla Capital: investment, 201905 existing investor Tekla Capital Management LLC |
2019-05-08 |
| Therachon–Versant Ventures: investment, 201905 existing investor Versant Ventures |
2019-05-08 |
![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo-2019.png){kind=logo}
Date![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
